Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.
暂无分享，去创建一个
A. Drilon | B. Geoerger | J. Grilley-Olson | D. Hong | C. M. Tilburg | B. Childs | A. Farago | D. Ziegler | F. Doz | D. Sohal | S. DuBois | Cornelis M. van Tilburg | C. V. van Tilburg | M. Cox | F. Doz | N. Ku | S. Nanda | Cornelis M. van Tilburg | F. Doz